Groundbreaking discovery of mechanism that controls obesity, atherosclerosis

2012-07-06

(Press-News.org) A*STAR scientists from the Institute of Molecular and Cell Biology (IMCB) and the Singapore Bioimaging Consortium (SBIC) have discovered a new signalling pathway that controls both obesity and atherosclerosis. The team demonstrated, for the first time, that mice deficient in the Wip1 gene were resistant to weight gain and atherosclerosis via regulation of the Ataxia telangiectasia mutated gene (ATM) and its downstream signalling molecule mTor. These groundbreaking findings were published in the journal Cell Metabolism on 3rd July and may provide significant new avenues for therapeutic interventions for obesity and atherosclerosis.

Obesity and atherosclerosis-related diseases account for over one-third of deaths in the Western world. Controlling these conditions remains a major challenge due to an incomplete understanding of the molecular pathways involved. Atherosclerosis, a progressive disease of the large arteries, is an underlying cause of many cardiovascular diseases. In Singapore, 10.8% of our population is obese and cardiovascular disease accounted for 31.9% of all deaths in 2010.

Obesity and atherosclerosis are accompanied by the accumulation of lipid droplets in adipocytes (fat cells) and in foam cells respectively. Foam cells can subsequently rupture, damaging blood vessels, and contributing to further progression of atherosclerosis. The scientists discovered that Wip1 deficient mice, even when fed a high-fat diet, were resistant to obesity and atherosclerosis by preventing the accumulation of lipid droplets. This appeared to be through increased autophagy, the normal process by which the body degrades its own cellular components. They showed that the Wip1 deficient mice exhibited increased activity of ATM which decreased mTor signalling, resulting in increased autophagy. This degraded the lipid droplets and suppressed obesity and atherosclerosis.

"This is the first time that Wip1-dependent regulation of ATM-mTor pathway has been linked to authophagy and cholesterol efflux thus providing an entirely new avenue for treatment of obesity and atherosclerosis," said Dr Dmitry Bulavin, Senior Principal Investigator at IMCB and lead author of this paper.

Mapping the mechanism to cancer

The scientists are hopeful that this ATM-mTor pathway could similarly map onto cancer to suppress tumour progression. Similar to suppression of obesity and atherosclerosis, activation of autophagy in cancer cells could result in degradation of cellular content that is essential for cancer cells to sustain rapid proliferation. This, in turn, will result in suppression of cancer growth.

Said Dr Dmitry Bulavin, "We are building on this research to investigate if the same mechanism could also control tumour progression and hence potentially unlock new therapeutic treatments targeting Wip1, ATM and mTor in cancer as well and the preliminary results are promising."

This discovery also adds to the growing significance of ATM as an important gene with a key role in protecting us from major pathological conditions. Previous work has established Wip1-dependent regulation of ATM as a potent regulator of tumorigenesis via activation of tumour-suppressor p53. Together, these three pathological conditions - obesity, atherosclerosis and cancer - account for more than 70% of mortality worldwide, making ATM-related pathways very attractive therapeutic targets.

8Prof Hong Wanjin, Executive Director of IMCB, said, "This is the first time that these important molecules have been integrated into a linear pathway that plays a prominent role in controlling obesity and atherosclerosis. It is a fine example of how fundamental research can shed light on biological and medical questions to potentially open new avenues of formulating therapeutic strategies for the benefit of patients."

INFORMATION:

Notes for Editor:

The research findings described in this news release can be found in the July 3rd print issue of Cell Metabolism under the title "Wip1-dependent regulation of autophagy, obesity and atherosclerosis" by Xavier Le Guezennec1, Anna Brichkina1, Yi-Fu Huang1, Elena Kostromina2, Weiping Han2, Dmitry V Bulavin*1.

1 Institute of Molecular and Cell Biology, 61 Biopolis Drive, Proteos 138673, Singapore

2 Laboratory of Metabolic Medicine, Singapore Bioimaging Consortium, Biomedical Sciences Institutes, 11 Biopolis Way, Helios 138667, Singapore

AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (A*STAR)

Enclosed:

Annex A – Two aortas stained for atherosclerosis

For media queries and clarifications, please contact:

Ong Siok Ming (Ms)
Senior Officer, Corporate Communications
Agency for Science, Technology and Research
Tel: (+65) 6826 6254
Email: ong_siok_ming@a-star.edu.sg

About Institute of Molecular and Cell Biology (IMCB)

The Institute of Molecular and Cell Biology (IMCB) is a member of Singapore's Agency for Science, Technology and Research (A*STAR) and is funded through A*STAR's Biomedical Research Council (BMRC). It is a world-class research institute that focuses its activities on six major fields: Cell Biology, Developmental Biology, Genomics, Structural Biology, Infectious Diseases, Cancer Biology and Translational Research, with core strengths in cell cycling, cell signalling, cell death, cell motility and protein trafficking. Its achievements include leading an international consortium that successfully sequenced the entire pufferfish (fugu) genome. The IMCB was awarded the Nikkei Prize 2000 for Technological Innovation in recognition of its growth into a leading international research centre and its collaboration with industry and research institutes worldwide. Established in 1987, the Institute currently has 26 independent research groups, eight core facilities and 300 researchers.

For more information about IMCB, please visit www.imcb.a-star.edu.sg

About the Singapore Bioimaging Consortium (SBIC)

The Singapore Bioimaging Consortium (SBIC) is a research consortium of the Agency for Science, Technology and Research (A*STAR) in Singapore. SBIC aims to build a coordinated national programme for imaging research, bringing together substantial strengths in the physical sciences and engineering and those in the biomedical sciences. It seeks to identify and consolidate the various bioimaging capabilities across local research institutes, universities and hospitals, in order to speed the development of biomedical research discoveries. SBIC has built up an extensive network of partners, through collaborations and joint appointments with research institutes, university and clinical departments, and the industry. Its partners include the Singapore Institute for Clinical Sciences, the NUS Chemistry Department, the National Cancer Centre, Duke-NUS, Agilent, Bruker, Bayer, GlaxoSmithKline, Takeda, and Merck.

For more information about SBIC, please visit www.sbic.a-star.edu.sg.

About the Agency for Science, Technology and Research (A*STAR)

The Agency for Science, Technology and Research (A*STAR) is the lead agency for fostering world-class scientific research and talent for a vibrant knowledge-based and innovation-driven Singapore. A*STAR oversees 14 biomedical sciences and physical sciences and engineering research institutes, and six consortia & centres, located in Biopolis and Fusionopolis as well as their immediate vicinity. A*STAR supports Singapore's key economic clusters by providing intellectual, human and industrial capital to its partners in industry. It also supports extramural research in the universities, and with other local and international partners.

For more information about A*STAR, please visit www.a-star.edu.sg.

END

ELSE PRESS RELEASES FROM THIS DATE:

Yak genome provides new insights into high altitude adaptation

2012-07-06

July 5, 2012, Shenzhen, China – An international team, led by Lanzhou University, comprising BGI, the world's largest genomics organization, Institute of Kunming Zoology, Chinese Academy of Sciences as well as the other 12 institutes, has completed the genomic sequence and analyses of a female domestic yak, which provides important insights into understanding mammalian divergence and adaptation at high altitude. This study was recently published online in Nature Genetics. Scienceshot made a timely comment on yak genome themed "What gets yak high ?" As an iconic symbol ...

Scripps Florida scientists identify critical 'quality control' for cell growth

2012-07-06

JUPITER, FL, July 5, 2012 – Scientists from the Florida campus of The Scripps Research Institute have identified a series of intricate biochemical steps that lead to the successful production of proteins, the basic working units of any cell. The study, which appears in the July 6, 2012 edition of the journal Cell, sheds light on the assembly of a structure called the ribosome, a large and complex protein-producing machine inside all living cells. Ribosomes are the targets of many commercially used antibiotics and represent a promising area of research because of the ...

How a protein meal tells your brain you’re full

2012-07-06

Feeling full involves more than just the uncomfortable sensation that your waistband is getting tight. Investigators reporting online on July 5th in the Cell Press journal Cell have now mapped out the signals that travel between your gut and your brain to generate the feeling of satiety after eating a protein-rich meal. Understanding this back and forth loop between the brain and gut may pave the way for future approaches in the treatment and/or prevention of obesity. Food intake can be modulated through mu-opioid receptors (MORs, which also bind morphine) on nerves found ...

Like it or not, Facebook and friends can be used to influence health behavior

2012-07-06

Most people call it the "art" of persuasion, but public health researchers at the University of Southern California (USC) are trying to pinpoint the "science" behind social influence. They hope a better understanding of human interactions — both face-to-face and online — can help prevent disease and promote general health. Whether the goal is to curb smoking at a local school or to reduce the spread of sexually transmitted diseases within a community, it is important to understand the social structure of the group and the dynamics of influence at play, says Thomas W. ...

Climate change suspended reef growth for 2 millennia

2012-07-06

MELBOURNE, FLA.—Climate change drove coral reefs to a total ecosystem collapse lasting thousands of years, according to a paper published this week in Science. The paper shows how natural climatic shifts stopped reef growth in the eastern Pacific for 2,500 years. The reef shutdown, which began 4,000 years ago, corresponds to a period of dramatic swings in the El Niño–Southern Oscillation (ENSO). "As humans continue to pump greenhouse gases into the atmosphere, the climate is once again on the threshold of a new regime, with dire consequences for reef ecosystems unless we ...

Novel nanotherapeutic delivers clot-busting drugs directly to obstructed blood vessels

2012-07-06

VIDEO: A blood clot within a mouse artery disappears following the injection of a clot-busting, shear-activated nanotherapeutic. The bright areas are fluorescent-labeled platelets. Click here for more information. Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University have developed a novel biomimetic strategy that delivers life-saving nanotherapeutics directly to obstructed blood vessels, dissolving blood clots before they cause ...

Researchers find a brain center for social choices

2012-07-06

DURHAM, N.C. -- Although many areas of the human brain are devoted to social tasks like detecting another person nearby, a new study has found that one small region carries information only for decisions during social interactions. Specifically, the area is active when we encounter a worthy opponent and decide whether to deceive them. A brain imaging study conducted by researchers at the Duke Center for Interdisciplinary Decision Science (D-CIDES) put human subjects through a functional MRI brain scan while playing a simplified game of poker against a computer and human ...

Diabetes drug makes brain cells grow

2012-07-06

The discovery is an important step toward therapies that aim to repair the brain not by introducing new stem cells but rather by spurring those that are already present into action, says the study's lead author Freda Miller of the University of Toronto-affiliated Hospital for Sick Children. The fact that it's a drug that is so widely used and so safe makes the news all that much better. Earlier work by Miller's team highlighted a pathway known as aPKC-CBP for its essential role in telling neural stem cells where and when to differentiate into mature neurons. As it happened, ...

Gladstone scientists identify critical process in stem cell development

2012-07-06

SAN FRANCISCO, CA--July 5, 2012--Scientists at the Gladstone Institutes have discovered that environmental factors critically influence the growth of a type of stem cell--called an iPS cell--that is derived from adult skin cells. This discovery offers newfound understanding of how these cells form, while also advancing science closer to stem cell-based therapies to combat disease. Researchers in the laboratory of Gladstone Senior Investigator Shinya Yamanaka, MD, PhD, have for the first time shown that protein factors released by other cells affect the "reprogramming" ...

Eddies, not sunlight, spur annual bloom of tiny plants in North Atlantic

2012-07-06

On a recent expedition to the inhospitable North Atlantic Ocean, scientists at the University of Washington and collaborators studying the annual growth of tiny plants were stumped to discover that the plankton had started growing before the sun had a chance to offer the light they need for their growth spurt. For decades, scientists have known that springtime brings the longer days and calmer seas that force phytoplankton near the surface, where they get the sunlight they need to flourish. But in research results published this week in the journal Science, scientists ...

Groundbreaking discovery of mechanism that controls obesity, atherosclerosis

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: